Mode
Text Size
Log in / Sign up
N/A N=70 Randomized Double-blind Treatment

Does Radiofrequency Ablation of the Articular Nerves of the Knee Prior to Total Knee Replacement Improve Pain Outcomes

Arthroplasty, Replacement, Knee

Enrolled (actual)
70
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcome: Primary: Opioid Consumption After Surgery — 192; 144 Morphine Equivalents (ME) — p=.978

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Radiofrequency Ablation (RFA) (Procedure); Simulated Radiofrequency Ablation (RFA) (Procedure)
Age
Adult, Older Adult · 30+ yrs
Sex
All
Sponsor
Northwestern University
Primary completion
Jun 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Opioid Consumption After Surgery
192; 144 .978
SECONDARY
Oral Morphine Equivalent Milligrams at Baseline.
0; 0
SECONDARY
Oral Morphine Equivalents at Baseline Compared to 48 Hours Post-operative.
-187; -191 .978
SECONDARY
Medication Quantification Scale III (MQSIII) Score 48 Hours Post-operative.
33; 35 .371
SECONDARY
Number of Stairs Climbed on Post-operative Day 2.
7; 8 .325
SECONDARY
Distance Walked on Post-operative Day 2.
216; 232 .466
SECONDARY
Western Ontario and McMaster Universities Arthritis Index (WOMAC) Score 6 Months Post Operative
8; 9 .368

Summary

More than 300,000 total knee joint replacement surgeries are performed per year in the United States and safe, effective management of post-operative pain in these patients, often elderly, deconditioned, obese, or with co-morbid diseases like sleep apnea, can be challenging and often require a multidisciplinary, multimodal approach. Opiates have been a mainstay of treatment in the post-operative period with varying degrees of success and complications. Inadequately controlled postoperative pain is not uncommon. Poorly controlled pain inhibits early mobilization and hinders post-operative physical therapy. A new paradigm for treating post-operative pain following total knee replacement may be the use of cooled radiofrequency ablation (C-RFA) of the articular sensory nerve supply of the knee capsule prior to surgery, to desensitize the knee by blocking sensory afferents to the anterior capsule and thereby decrease post-operative pain. There are several publications that have demonstrated the use of RFA in patients with chronic knee pain from osteoarthritis however the use of RFA in the preoperative management of pain in patients undergoing total knee joint replacement has not been investigated. The aim of this study is to determine if patients undergoing unilateral total knee replacement obtain any post-operative pain relieving benefits from C-RFA of the articular sensory nerve supply when performed prior to surgery, as compared to sham controls who receive only local anesthetic injections of these same nerves without the benefit of ablation treatment.

Eligibility Criteria

Inclusion Criteria

  • osteoarthritis of the knee scheduled to undergo their first unilateral knee joint replacement
  • willingness to undergo fluoroscopy-guided C-RFA or sham treatment

Exclusion Criteria

  • pregnancy,
  • severe cardiac/pulmonary compromise,
  • acute illness/infection,
  • coagulopathy
  • bleeding disorder,
  • allergic reactions,
  • contraindications to a local anesthetic
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02746874). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search